Materials and Method
For allpatients treated with PBTat our centre, the baseline characteristics, imaging features, pathology including molecular information, multimodality treatment, proton therapy technique, plan parameters, quality assurance metrics, set-up and delivery parameters, treatment response and their subsequent follow-up information are being routinely captured in a prospectively maintained registry. The present work focusses on reporting baseline characteristics, diagnosis, treatment delivery parameters, treatment related acute toxicity and follow-up information of all children and young adults <25 years of age consecutively treatedpatients treated at our centre.